{"id":231824,"date":"2026-09-04T15:13:27","date_gmt":"2026-09-04T09:43:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=231824"},"modified":"2026-09-04T15:13:30","modified_gmt":"2026-09-04T09:43:30","slug":"is-advanced-enzyme-technologies-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-advanced-enzyme-technologies-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Advanced Enzyme Technologies a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Advanced Enzyme Technologies share price around Rs 298. 28.9% below 52-week high of Rs 419. Q1 FY27 revenue Rs 203 crore, up 4.1% YoY. PAT Rs 39 crore, down 4.6%. PE 19x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Advanced Enzyme Technologies’ Q1 FY27 results were mixed, with revenue at Rs 203 crore but PAT falling 5% to Rs 39 crore. The Advanced Enzyme Technologies share price near Rs 298 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Advanced Enzyme Technologies is a good buy right now.<\/p>\n<\/div>\n

The Advanced Enzyme Technologies share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Advanced Enzyme Technologies is a manufacturer of industrial and specialty enzymes for pharma, food and other sectors, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 203 crore, up 4.1% year on year, while profit after tax came in at Rs 39 crore, down 4.6% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Advanced Enzyme Technologies share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Advanced Enzyme Technologies share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n